Clinical Trial Update: Safety and Efficacy Study of BETAXON 0.5% and AZOPT 1.0% in Pediatric Patients With Glaucoma or Ocular Hypertension [Phase 3]

View source ↗

Summary

Completed Phase 3 trial assessing the safety and efficacy of BETAXON 0.5% and AZOPT 1.0% in pediatric patients with glaucoma or ocular hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• AZOPT 1.0% (brinzolamide)
• BETAXON 0.5% (betaxolol)

Snippet

Sponsor: Alcon Research | Conditions: Glaucoma, Ocular Hypertension | Phase 3 | Status: COMPLETED